)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Coegin Pharma (COEGIN) investor relations material
Coegin Pharma Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary20 Nov, 2025
Executive summary
Transitioned from a development-focused biotech to a commercial company in Q3 2025, marked by first commercial purchase orders for Follicopeptide and establishment of an in-house production facility in Denmark.
Signed strategic distribution agreements with Gents AB (Sweden), Mercapharm (Poland), and Hårklinikken, supporting international product launch strategy.
Launched a complementary Follicopeptide product, with market introduction planned for March 2026.
Financial highlights
Net revenue was 0 TSEK for both Q3 and the first nine months of 2025 (unchanged year-over-year).
Operating profit for Q3 2025 was -4,058 TSEK (improved from -5,586 TSEK in Q3 2024); for the first nine months, -13,595 TSEK (improved from -16,198 TSEK year-over-year).
Earnings per share for Q3 2025 was -0.16 SEK (vs. -0.28 SEK in Q3 2024); for the first nine months, -0.55 SEK (vs. -1.08 SEK year-over-year).
Cash at period end was 7,370 TSEK (down from 9,469 TSEK a year earlier).
Equity at period end was 11,646 TSEK (down from 33,470 TSEK a year earlier).
Outlook and guidance
Initial product launches for Follicopeptide are scheduled for December 2025, with further launches and portfolio expansion planned for 2026.
Targeting balanced cash flow in the second half of 2026 and reduced reliance on external financing.
A measured financing plan is in progress to ensure sufficient working capital through Q2–Q4 2026.
Details on Q2-Q4 2026 financing plan
Follicopeptide's competitive edge and market strategy
Future of Phase 2 drug candidate AVX001
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Coegin Pharma earnings date
Q4 202526 Feb, 2026
Next Coegin Pharma earnings date
Q4 202526 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Coegin Pharma AB is a Sweden-based biotechnology company focused on developing innovative therapies for inflammatory-driven diseases. The company leverages its expertise in molecular targeting to develop pharmaceutical candidates addressing conditions such as cancer, fibrosis, and chronic inflammation. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage